Mounjaro jabs on the NHS: who qualifies, what the wait looks like, and what else is available

What does the NHS actually require before it'll prescribe Mounjaro jabs?

The rollout follows NICE technology appraisal TA1026, published in December 2024 and updated in September 2025. It set out a phased approach tied to BMI and a list of five qualifying conditions: type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea, and cardiovascular disease.

The first cohort, active from June 2025, requires a BMI of 40 or above plus four or more of those five conditions. A second cohort opened around 23 June 2026 for adults with a BMI between 35 and 39.9 who also have four or more conditions. A third cohort is expected around March 2027, BMI of 40 or above with three conditions. Each step opens the door a little wider, but the pace is deliberate.

For some ethnic backgrounds, the BMI thresholds shift down by 2.5 kg/m² throughout all phases, South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds are covered by this adjustment under UK guidance. Even so, meeting a threshold doesn't guarantee timely access: every NHS patient must be enrolled in wraparound lifestyle support, and waiting lists in specialist services can be long. If you want to understand exactly what hoops you need to clear, our guide to Mounjaro on the NHS explains the qualifying criteria and what the phasing means in practice.

Can a GP prescribe Mounjaro jabs, or does it have to go through a specialist?

From 1 April 2026, GP practices can prescribe tirzepatide directly under the new QOF 2026/27 contract, which is a real shift from the earlier specialist-only model. In theory, it means you might not need a referral to a hospital or tier-3 weight management service. In practice, participation in the new contract is optional. Some practices have signed up; others haven't, and you won't always know without asking. Area matters too, commissioning decisions vary across ICBs.

A common misconception is that the NHS prescription route is now straightforward for most people with obesity. It isn't, not yet. The criteria remain strict and the infrastructure to support widespread prescribing is still being built. If you'd like a clear picture of how the Mounjaro jab works through the NHS, including what the phasing means for when you might realistically qualify, that page sets it out in full. That may change (the phasing exists precisely to allow the NHS to scale) but for people who need treatment now and don't meet the current thresholds, waiting isn't the only option. Buying Mounjaro through a private clinical service is a legal route, subject to a prescriber assessing your suitability first.

What are the eligibility criteria for private Mounjaro jabs?

The licensed private criteria are set out in the medicine's SmPC and are broader than the current NHS thresholds. Adults with a BMI of 30 or above qualify, as do adults with a BMI of 27 or above if at least one weight-related condition is present, prediabetes, hypertension, high cholesterol, and obstructive sleep apnoea all count among others. A prescriber reviews the full clinical picture, including any medicines you're already taking and any conditions that might affect suitability.

Private supply must still go through a GPhC-registered pharmacy and still requires a genuine clinical assessment. If you're considering this route, it's worth checking any pharmacy you use against the GPhC register, that's the quickest way to confirm a service is legitimate. Sellers offering tirzepatide without a proper consultation are a red flag, not a shortcut. The MHRA has been clear on the risks of buying weight-loss medicines from unverified sources, and enforcement has been active.

For a fuller look at what private treatment involves and how costs compare, the Mounjaro pricing page walks through what a legitimate price typically covers.

If you want Mounjaro jabs privately, what does the process actually look like?

The private route is more straightforward than people often expect. A consultation collects your health history, current medicines, and weight details. At a service like ours, a GPhC-registered Independent Prescriber (a real clinician, not automated software) reads the responses the same day. Identity and weight are verified as part of the process. If treatment is clinically appropriate, the prescription is issued and the order dispatches the same working day for free next-working-day tracked delivery.

There's no referral to chase and no waiting list. That doesn't mean it's suitable for everyone (the prescriber decides that individually) but for people who've looked into buying Mounjaro online and want to understand what a safe, regulated version of that looks like, the steps are the same ones you'd follow with any prescription medicine: clinical assessment first, supply afterwards. Our Mounjaro overview page covers the medicine itself in more depth, including how the titration schedule works and what side effects to expect. When you're ready to find out if it's suitable for you, speak to our prescribers through a free consultation.